HF
SBFM

HRT Financial’s Sunshine Biopharma SBFM Stock Holding History

HRT Financial’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-225
Closed -$18K – 3041
2024
Q2 		$18K Buy
225
+224
+22,400% +$107K ﹤0.01% 1943
2024
Q1 		$1K Buy
+1
New +$2.94K ﹤0.01% 2176
2023
Q4 		– Sell
-1
Closed -$5K – 2981
2023
Q3 		$5K Buy
+1
New +$8.95K ﹤0.01% 2185

Other funds holding SBFM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

HRT Financial's SBFM Position: Q3 2024 in Review

HRT Financial sold out of Sunshine Biopharma (SBFM) in Q3 2024, closing a stake of 225 shares — an estimated $18K sold.

HRT Financial first reported a position in SBFM in Q3 2023 and held it in 3 quarters. The position peaked at $18K in Q2 2024. 3 funds tracked by Wall St. Rank hold SBFM as of Q3 2024.

  • HRT Financial reported no remaining Sunshine Biopharma position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 225 Sunshine Biopharma shares in Q3 2024, an estimated $18K.
  • HRT Financial first reported a position in Sunshine Biopharma in Q3 2023 and held it in 3 quarters.
  • HRT Financial's Sunshine Biopharma position peaked at $18K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.